Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

J. Shapiro; J.J.B. van Lanschot; M.C.C.M. Hulshof; P. van Hagen; M.I.V. Henegouwen; B.P.L. Wijnhoven; H.W.M. van Laarhoven; G.A.P. Nieuwenhuijzen; G.A.P. Hospers; J.J. Bonenkamp; M.A. Cuesta; R.J.B. Blaisse; O.R.C. Busch; F.J.W. Ten Kate; G.J.M. Creemers; C.J.A. Punt; J.T.M. Plukker; H.M.W. Verheul; E.J.S. Bilgen; H. van Dekken; M.J.C. van der Sangen; T. Rozema; K. Biermann; J.C. Beukema; A.H.M. Piet; C.M. van Rij; J.G. Reinders; H.W. Tilanus; E.W. Steyerberg; A. van der Gaast

doi:10.1016/S1470-2045(15)00040-6

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

J. Shapiro, J.J.B. van Lanschot, M.C.C.M. Hulshof, P. van Hagen, M.I.V. Henegouwen, B.P.L. Wijnhoven, H.W.M. van Laarhoven, G.A.P. Nieuwenhuijzen, G.A.P. Hospers, J.J. Bonenkamp, M.A. Cuesta, R.J.B. Blaisse, O.R.C. Busch, F.J.W. Ten Kate, G.J.M. Creemers, C.J.A. Punt, J.T.M. Plukker, H.M.W. Verheul, E.J.S. Bilgen, H. van DekkenM.J.C. van der Sangen, T. Rozema, K. Biermann, J.C. Beukema, A.H.M. Piet, C.M. van Rij, J.G. Reinders, H.W. Tilanus, E.W. Steyerberg, A. van der Gaast

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1090-1098
Journal	Lancet Oncology
Volume	16
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(15)00040-6
Publication status	Published - 2015

Access to Document

10.1016/S1470-2045(15)00040-6

Cite this

Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., Henegouwen, M. I. V., Wijnhoven, B. P. L., ... van der Gaast, A. (2015). Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncology, 16(9), 1090-1098. https://doi.org/10.1016/S1470-2045(15)00040-6

Shapiro, J. ; van Lanschot, J.J.B. ; Hulshof, M.C.C.M. ; van Hagen, P. ; Henegouwen, M.I.V. ; Wijnhoven, B.P.L. ; van Laarhoven, H.W.M. ; Nieuwenhuijzen, G.A.P. ; Hospers, G.A.P. ; Bonenkamp, J.J. ; Cuesta, M.A. ; Blaisse, R.J.B. ; Busch, O.R.C. ; Ten Kate, F.J.W. ; Creemers, G.J.M. ; Punt, C.J.A. ; Plukker, J.T.M. ; Verheul, H.M.W. ; Bilgen, E.J.S. ; van Dekken, H. ; van der Sangen, M.J.C. ; Rozema, T. ; Biermann, K. ; Beukema, J.C. ; Piet, A.H.M. ; van Rij, C.M. ; Reinders, J.G. ; Tilanus, H.W. ; Steyerberg, E.W. ; van der Gaast, A. / Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. In: Lancet Oncology. 2015 ; Vol. 16, No. 9. pp. 1090-1098.

@article{3deb204e795d46b19af49d80a8e7e1e9,

title = "Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial",

author = "J. Shapiro and {van Lanschot}, J.J.B. and M.C.C.M. Hulshof and {van Hagen}, P. and M.I.V. Henegouwen and B.P.L. Wijnhoven and {van Laarhoven}, H.W.M. and G.A.P. Nieuwenhuijzen and G.A.P. Hospers and J.J. Bonenkamp and M.A. Cuesta and R.J.B. Blaisse and O.R.C. Busch and {Ten Kate}, F.J.W. and G.J.M. Creemers and C.J.A. Punt and J.T.M. Plukker and H.M.W. Verheul and E.J.S. Bilgen and {van Dekken}, H. and {van der Sangen}, M.J.C. and T. Rozema and K. Biermann and J.C. Beukema and A.H.M. Piet and {van Rij}, C.M. and J.G. Reinders and H.W. Tilanus and E.W. Steyerberg and {van der Gaast}, A.",

year = "2015",

doi = "10.1016/S1470-2045(15)00040-6",

language = "Undefined/Unknown",

volume = "16",

pages = "1090--1098",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "9",

}

Shapiro, J, van Lanschot, JJB, Hulshof, MCCM, van Hagen, P, Henegouwen, MIV, Wijnhoven, BPL, van Laarhoven, HWM, Nieuwenhuijzen, GAP, Hospers, GAP, Bonenkamp, JJ, Cuesta, MA, Blaisse, RJB, Busch, ORC, Ten Kate, FJW, Creemers, GJM, Punt, CJA, Plukker, JTM, Verheul, HMW, Bilgen, EJS, van Dekken, H, van der Sangen, MJC, Rozema, T, Biermann, K, Beukema, JC, Piet, AHM, van Rij, CM, Reinders, JG, Tilanus, HW, Steyerberg, EW & van der Gaast, A 2015, 'Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial', Lancet Oncology, vol. 16, no. 9, pp. 1090-1098. https://doi.org/10.1016/S1470-2045(15)00040-6

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. / Shapiro, J.; van Lanschot, J.J.B.; Hulshof, M.C.C.M.; van Hagen, P.; Henegouwen, M.I.V.; Wijnhoven, B.P.L.; van Laarhoven, H.W.M.; Nieuwenhuijzen, G.A.P.; Hospers, G.A.P.; Bonenkamp, J.J.; Cuesta, M.A.; Blaisse, R.J.B.; Busch, O.R.C.; Ten Kate, F.J.W.; Creemers, G.J.M.; Punt, C.J.A.; Plukker, J.T.M.; Verheul, H.M.W.; Bilgen, E.J.S.; van Dekken, H.; van der Sangen, M.J.C.; Rozema, T.; Biermann, K.; Beukema, J.C.; Piet, A.H.M.; van Rij, C.M.; Reinders, J.G.; Tilanus, H.W.; Steyerberg, E.W.; van der Gaast, A.

In: Lancet Oncology, Vol. 16, No. 9, 2015, p. 1090-1098.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

AU - Shapiro, J.

AU - van Lanschot, J.J.B.

AU - Hulshof, M.C.C.M.

AU - van Hagen, P.

AU - Henegouwen, M.I.V.

AU - Wijnhoven, B.P.L.

AU - van Laarhoven, H.W.M.

AU - Nieuwenhuijzen, G.A.P.

AU - Hospers, G.A.P.

AU - Bonenkamp, J.J.

AU - Cuesta, M.A.

AU - Blaisse, R.J.B.

AU - Busch, O.R.C.

AU - Ten Kate, F.J.W.

AU - Creemers, G.J.M.

AU - Punt, C.J.A.

AU - Plukker, J.T.M.

AU - Verheul, H.M.W.

AU - Bilgen, E.J.S.

AU - van Dekken, H.

AU - van der Sangen, M.J.C.

AU - Rozema, T.

AU - Biermann, K.

AU - Beukema, J.C.

AU - Piet, A.H.M.

AU - van Rij, C.M.

AU - Reinders, J.G.

AU - Tilanus, H.W.

AU - Steyerberg, E.W.

AU - van der Gaast, A.

PY - 2015

Y1 - 2015

U2 - 10.1016/S1470-2045(15)00040-6

DO - 10.1016/S1470-2045(15)00040-6

M3 - Article

VL - 16

SP - 1090

EP - 1098

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 9

ER -